Latest News in the pharma Industry

Market News

Scholar Rock announces $47 million Series C financing to advance innovative pipeline

Scholar Rock announces $47 million Series C financing to advance innovative pipeline

3 Jan 2018

SRK-015 to move into clinical development for Spinal Muscular Atrophy (SMA) in first half of 2018; development in additional neuromuscular disorders to follow.

Read more 
Recipharm acquires remaining shares in Nitin Lifesciences

Recipharm acquires remaining shares in Nitin Lifesciences

2 Jan 2018

The transaction will allow Recipharm to combine and better exploit operational synergies with the company's other Indian business.

Read more 
Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

2 Jan 2018

Martyn Davies recognised for his contribution to UK science and his ground-breaking achievements in pharmaceutical research and drug development.

Read more 
Novel Sorrento CAR-T technology a potential “game-changer

Novel Sorrento CAR-T technology a potential “game-changer

2 Jan 2018

Company envisions the development and IND filings of multiple “next-frontier” CAR-T programs in 2018 and beyond, which will position the company as a potential major player in the fast-growing CAR-T space of immunotherapies against cancers.

Read more 
ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

29 Dec 2017

Libbs will commercialize the product in Brazil under the brand name Zedora.

Read more 
FDA approves first generic for Estrace Cream

FDA approves first generic for Estrace Cream

29 Dec 2017

Mylan now offers estradiol in four delivery methods.

Read more 
Shire files for FDA approval of a new plasma manufacturing facility

Shire files for FDA approval of a new plasma manufacturing facility

28 Dec 2017

The additional capacity from this site is a key element to support the growth in the company's Immunology franchise.

Read more 
Teva launches generic version of Reyataz in the US

Teva launches generic version of Reyataz in the US

28 Dec 2017

The exclusive launch of Teva's generic version of Reyataz marks the company's fifth generic product offering for the treatment of HIV-1 infection.

Read more 
Novartis drug Tasigna approved by FDA

Novartis drug Tasigna approved by FDA

28 Dec 2017

First and only CML therapy with Treatment-free Remission data in its label.

Read more 
FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

27 Dec 2017

Clinical studies showed 95% symptom improvement at one minute and reduced redness for up t 8 hours.

Read more 
AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

27 Dec 2017

iMatrix recombinant Laminin-511 E8 protein fragments permit ES/iPS cells to be maintained in xeno-free, feeder-free culture conditions enabling easy application in medical trials.

Read more 
Allergan acknowledges Appeals Court decision for Combigan

Allergan acknowledges Appeals Court decision for Combigan

27 Dec 2017

Allergan plans to file petitions for rehearing of the appeals court decision and has asserted a new Orange Book patent against Sandoz's generic version of Combigan.

Read more